BHARAT BIOTECH

In News

Pandorum Tech in pact with Bharat Biotech's Nucelion for exosome-based therapeutics - The Times of India

The Times of India - Jan 06, 2026

Hyderabad-based Bharat Biotech, Pandorum Tech tie up for regenerative therapy - Deccan Herald

Deccan Herald - Jan 06, 2026

GSK licenses Shigella vaccine candidate to Bharat Biotech for continued development - GSK

GSK - Jun 12, 2025

GSK, Bharat Biotech to slash the price of first malaria vaccine to less than $5 per dose by 2028 - Fierce Pharma

Fierce Pharma - Jun 25, 2025

Bharat Biotech acquires licence to develop GSK's Shigella vaccine - Pharmaceutical Technology

Pharmaceutical Technology - Jun 13, 2025

GSK offloads shigella vaccine to Bharat ahead of phase 3, vows to support fundraising - Fierce Biotech

Fierce Biotech - Jun 12, 2025

Bharat Biotech opens $75m CGT facility in India - BioProcess International

BioProcess International - Mar 31, 2025

GSK Licenses altSonflex1-2-3 Shigella Vaccine to Bharat Biotech - Pharmaceutical Executive

Pharmaceutical Executive - Jun 12, 2025

Pandorum, Bharat Biotech Unit Forge APAC Exosome Therapy Manufacturing Pact - Whalesbook

Whalesbook - Jan 06, 2026

Pandorum teams up with Bharat Biotech subsidiary - Telangana Today

Telangana Today - Jan 06, 2026

Pandorum ties up with Bharat Biotech arm Nucelion to scale exosome therapies across APAC - Fortune India

Fortune India - Jan 06, 2026

Bharat Biotech, Biofabri in tech transfer deal for TB vaccine - The Economic Times

The Economic Times - Dec 23, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment